Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- Registration Number
- NCT00563381
- Lead Sponsor
- Boehringer Ingelheim
- Brief Summary
This is a randomised, double-blind, double-dummy, multinational, multicentre, parallel group trial comparing tiotropium (18 mcg) inhalation capsule via HandiHaler and salmeterol (50 mcg) via MDI in patients with COPD. There will be a two-week run-in period followed by a 52-week randomised treatment phase. Patients who withdraw prematurely from trial medication will be encouraged to remain in the trial and participate in follow-up telephone contacts until their predicted normal exit date from the trial (i.e. 52 weeks after taking the first dose of randomised treatment). The phone calls will be made at all scheduled visits.
The primary objective of this study is to compare the effect of tiotropium (18 mcg) inhalation capsule via HandiHaler with that of salmeterol (50 mcg) via MDI on COPD exacerbations.
The primary endpoint is time to first COPD exacerbation during the 52 week randomised treatment period. A COPD exacerbation will be defined as a complex of respiratory events / symptoms (increase or new onset) of more than one of the following: cough, sputum, wheezing, dyspnoea or chest tightness with at least one symptom lasting at least three days requiring treatment with antibiotics and/or systemic steroids and/or hospitalisation.
The onset of an exacerbation is defined as the onset of the first new or increased reported symptom. The end of the exacerbation should be recorded as defined by the investigator.
Only COPD exacerbations with onset during randomised treatment will be included in the analysis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 7376
-
All patients must have a diagnosis of chronic obstructive pulmonary disease (COPD) and must meet the following criteria at Visit 1:
Patients must have relatively stable, moderate to very severe airway obstruction with a post-bronchodilator FEV1 <=70% of predicted normal and FEV1 <=70% of FVC post-bronchodilator (i.e. 30 minutes after inhalation of 4 puffs of 100 µg salbutamol or equivalent SABA). Predicted normal values will be calculated according to ECSC.
For Height measured in inches Males: FEV1 predicted (L) = 4.30 x (height (inches) / 39.37)-0.029 x age (yrs) - 2.49 Females:FEV1 predicted (L) = 3.95 x (height (inches) / 39.37)-0.025 x age (yrs) - 2.60 For Height measured in metres Males: FEV1 predicted (L) = 4.30 x (height (metres)) - 0.029 x age (years) - 2.49 Females: FEV1 predicted (L) = 3.95 x (height (metres)) - 0.025 x age (years) - 2.60
-
All patients must sign an informed consent consistent with ICH-GCP guidelines prior to participation in the trial.
-
Male or female patients 40 years of age or older.
-
Patients with a history of at least one exacerbation within the past year requiring treatment with either antibiotics and/or systemic steroids and/or hospitalisation.
-
Patients must be current or ex-smokers with a smoking history of >= 10 pack-years. (Patients who have never smoked cigarettes must be excluded.)
-
Patients must be able to perform all study-related procedures including technically acceptable pulmonary function tests (PFTs).
-
Patients must be able to inhale medication in a competent manner from the HandiHaler and a metered dose inhaler (MDI).
-
Patients must be able to maintain records (patient daily diary card) during the study period as required in the protocol.
- Significant diseases other than COPD. A significant disease is defined as a disease or condition which, in the opinion of the investigator, may put the patient at risk because of participation in the study or may influence either the results of the study or the patients' ability to participate in the study.
- Patients with a diagnosis of asthma.
- Patients with a life-threatening pulmonary obstruction, or a history of cystic fibrosis.
- Patients with known active tuberculosis.
- Patients with a known symptomatic prostatic hyperplasia or bladder neck obstruction. Patients with symptomatically-controlled prostatic hyperplasia on medication may be included and should continue their medication.
- Patients with known narrow-angle glaucoma.
- Patients with a history of myocardial infarction within the year prior to Visit 1.
- Patients with a history of hospital admission for heart failure within the year prior to Visit 1.
- Patients with cardiac arrhythmia requiring medical or surgical treatment.
- Patients with severe cardiovascular disorders.
- Patients with a known hypersensitivity to anticholinergic drugs, beta-adrenergics, lactose or any other component of the medication delivery system.
- Patients with known moderate or severe renal insufficiency (known creatinine clearance of <= 50 mL/min).
- Patients with untreated known hypokalaemia.
- Patients with untreated known thyrotoxicosis.
- Patients with brittle/unstable diabetes mellitus.
- Patients with a history of and/or active significant alcohol or drug abuse. See exclusion criterion 1.
- Patients who have taken an investigational drug within 30 days or six half-lives (whichever is greater) prior to Screening Visit (Visit 1).
- Use of systemic corticosteroid medication at unstable doses (i.e less than six weeks on stable dose) or at doses in excess of the equivalent of 10 mg prednisolone per day or 20 mg every other day.
- Pregnant or nursing women or women of childbearing potential not using a medically approved means of contraception (i.e oral contraceptives, intrauterine devices, diaphragm or subdermal implants e.g Norplant) for at least three months prior to, and for the duration of the trial.
- Previous participation (receipt of randomised treatment) in this study.
- Patients who are currently participating in another study.
- Patients with any respiratory infection or COPD exacerbation in the four weeks prior to the Screening Visit (Visit 1) or during the run-in period should be postponed. In the case of a respiratory infection or COPD exacerbation during the run-in period, the latter may be extended up to four weeks.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Tiotropium + Placebo Tiotropium bromide patients inhale Tiotropium 18mcg once daily via HandiHaler and Placebo MDI twice daily Tiotropium + Placebo Placebo Salmeterol patients inhale Tiotropium 18mcg once daily via HandiHaler and Placebo MDI twice daily Salmeterol + Placebo Salmeterol patients inhale Salmeterol 50mcg twice daily via MDI and Placebo HandiHaler once daily Salmeterol + Placebo Placebo Tiotropium patients inhale Salmeterol 50mcg twice daily via MDI and Placebo HandiHaler once daily
- Primary Outcome Measures
Name Time Method First Occurrence of (Moderate or Severe) COPD Exacerbation 52 weeks First occurrence analysed by Cox regression as time to first exacerbation and reported as hazard ratio. An exacerbation was defined as an increase or new onset of more than 1 symptom (cough, sputum, wheezing, dyspnoea, chest tightness), with at least 1 symptom lasting at least 3 days and requiring treatment with systemic steroids and/or antibiotics (moderate exacerbation) or hospitalisation (severe exacerbation).
- Secondary Outcome Measures
Name Time Method COPD Exacerbations Per Patient-year Leading to Hospitalisation 52 weeks An exacerbation was defined as an increase or new onset of more than 1 symptom (cough, sputum, wheezing, dyspnoea, chest tightness), with at least 1 symptom lasting at least 3 days and requiring treatment with systemic steroids and/or antibiotics (moderate exacerbation) or hospitalisation (severe exacerbation).
Number of Participants With at Least One COPD Exacerbation 52 weeks An exacerbation was defined as an increase or new onset of more than 1 symptom (cough, sputum, wheezing, dyspnoea, chest tightness), with at least 1 symptom lasting at least 3 days and requiring treatment with systemic steroids and/or antibiotics (moderate exacerbation) or hospitalisation (severe exacerbation).
COPD Exacerbations Per Patient-year 52 weeks First Occurrence of COPD Exacerbation Leading to Hospitalization 52 weeks First occurrence analysed by Cox regression as time to first exacerbation leading to hospitalisation and reported as hazard ratio. An exacerbation was defined as an increase or new onset of more than 1 symptom (cough, sputum, wheezing, dyspnoea, chest tightness), with at least 1 symptom lasting at least 3 days and requiring treatment with systemic steroids and/or antibiotics (moderate exacerbation) or hospitalisation (severe exacerbation).
Number of Participants With at Least One COPD Exacerbation Leading to Hospitalisation 52 weeks An exacerbation was defined as an increase or new onset of more than 1 symptom (cough, sputum, wheezing, dyspnoea, chest tightness), with at least 1 symptom lasting at least 3 days and requiring treatment with systemic steroids and/or antibiotics (moderate exacerbation) or hospitalisation (severe exacerbation).
Occurrence of Premature Discontinuation of Trial Medication 52 weeks Occurrence analysed by Cox regression as time to premature discontinuation of trial medication and reported as hazard ratio
Number of Participants With Premature Discontinuation of Trial Medication 52 weeks First Occurrence of COPD Exacerbation or Discontinuation of Trial Medication Because of Worsening of Underlying Disease, Whichever Comes First 52 weeks First occurrence analysed by Cox regression as time to first exacerbation or discontinuation of trial medication because of worsening of underlying disease, whichever comes first and reported as hazard ratio. An exacerbation was defined as an increase or new onset of more than 1 symptom (cough, sputum, wheezing, dyspnoea, chest tightness), with at least 1 symptom lasting at least 3 days and requiring treatment with systemic steroids and/or antibiotics (moderate exacerbation) or hospitalisation (severe exacerbation).
First Occurrence of COPD Exacerbations Treated With Systemic Steroids 52 weeks First occurrence analysed by Cox regression as time to first exacerbation treated with systemic steroids and reported as hazard ratio. An exacerbation was defined as an increase or new onset of more than 1 symptom (cough, sputum, wheezing, dyspnoea, chest tightness), with at least 1 symptom lasting at least 3 days and requiring treatment with systemic steroids and/or antibiotics (moderate exacerbation) or hospitalisation (severe exacerbation).
First Occurrence of COPD Exacerbations Treated With Antibiotics 52 weeks First occurrence analysed by Cox regression as time to first exacerbation treated with antibiotics and reported as hazard ratio. An exacerbation was defined as an increase or new onset of more than 1 symptom (cough, sputum, wheezing, dyspnoea, chest tightness), with at least 1 symptom lasting at least 3 days and requiring treatment with systemic steroids and/or antibiotics (moderate exacerbation) or hospitalisation (severe exacerbation).
First Occurrence of COPD Exacerbations Treated With Systemic Steroids and Antibiotics 52 weeks First occurrence analysed by Cox regression as time to first exacerbation treated with systemic steroids and antibiotics and reported as hazard ratio. An exacerbation was defined as an increase or new onset of more than 1 symptom (cough, sputum, wheezing, dyspnoea, chest tightness), with at least 1 symptom lasting at least 3 days and requiring treatment with systemic steroids and/or antibiotics (moderate exacerbation) or hospitalisation (severe exacerbation).
COPD Exacerbations Treated With Systemic Steroids Per Patient-year 52 weeks An exacerbation was defined as an increase or new onset of more than 1 symptom (cough, sputum, wheezing, dyspnoea, chest tightness), with at least 1 symptom lasting at least 3 days and requiring treatment with systemic steroids and/or antibiotics (moderate exacerbation) or hospitalisation (severe exacerbation).
COPD Exacerbations Treated With Antibiotics Per Patient-year 52 weeks An exacerbation was defined as an increase or new onset of more than 1 symptom (cough, sputum, wheezing, dyspnoea, chest tightness), with at least 1 symptom lasting at least 3 days and requiring treatment with systemic steroids and/or antibiotics (moderate exacerbation) or hospitalisation (severe exacerbation).
COPD Exacerbations Treated With Systemic Steroids and Antibiotics Per Patient-year 52 weeks An exacerbation was defined as an increase or new onset of more than 1 symptom (cough, sputum, wheezing, dyspnoea, chest tightness), with at least 1 symptom lasting at least 3 days and requiring treatment with systemic steroids and/or antibiotics (moderate exacerbation) or hospitalisation (severe exacerbation).
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 1 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 2 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 3 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 4 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 7 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 8 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 9 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 10 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 5 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 6 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 11 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 12 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 13 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 14 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 15 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Pre-dose Morning PEFR Measured by Patients at Home During the First Four Months of Randomised Treatment (Weekly Means Will be Calculated), Week 16 16 weeks PEFR means peak expiratory flow rate and is measured in liter per minute
Trial Locations
- Locations (752)
205.389.1020 Boehringer Ingelheim Investigational Site
🇦🇹Feldbach, Austria
205.389.1002 Boehringer Ingelheim Investigational Site
🇦🇹Wien, Austria
205.389.1204 Boehringer Ingelheim Investigational Site
🇨🇿Brno-Kralovo Pole, Czech Republic
205.389.1230 Boehringer Ingelheim Investigational Site
🇨🇿Humpolec, Czech Republic
205.389.1208 Boehringer Ingelheim Investigational Site
🇨🇿Jaromer, Czech Republic
205.389.1227 Boehringer Ingelheim Investigational Site
🇨🇿Praha 5, Czech Republic
205.389.1219 Boehringer Ingelheim Investigational Site
🇨🇿Kyjov, Czech Republic
205.389.1407 Boehringer Ingelheim Investigational Site
🇫🇮Turku, Finland
205.389.1218 Boehringer Ingelheim Investigational Site
🇨🇿Litomerice, Czech Republic
205.389.1207 Boehringer Ingelheim Investigational Site
🇨🇿Neratovice, Czech Republic
205.389.1209 Boehringer Ingelheim Investigational Site
🇨🇿Plzen, Czech Republic
205.389.1216 Boehringer Ingelheim Investigational Site
🇨🇿Plzen, Czech Republic
205.389.1217 Boehringer Ingelheim Investigational Site
🇨🇿Praha 13, Czech Republic
205.389.1229 Boehringer Ingelheim Investigational Site
🇨🇿Praha 4, Czech Republic
205.389.1221 Boehringer Ingelheim Investigational Site
🇨🇿Strakonice, Czech Republic
205.389.1228 Boehringer Ingelheim Investigational Site
🇨🇿Prerov, Czech Republic
205.389.1210 Boehringer Ingelheim Investigational Site
🇨🇿Znojmo, Czech Republic
205.389.1415 Boehringer Ingelheim Investigational Site
🇫🇮Lohja, Finland
205.389.1231 Boehringer Ingelheim Investigational Site
🇨🇿Rokycany, Czech Republic
205.389.2303 Boehringer Ingelheim Investigational Site
🇱🇻Riga, Latvia
205.389.2404 Boehringer Ingelheim Investigational Site
🇱🇹Kaunas, Lithuania
205.389.2411 Boehringer Ingelheim Investigational Site
🇱🇹Klaipeda, Lithuania
205.389.2601 Boehringer Ingelheim Investigational Site
🇳🇴Elverum, Norway
205.389.2611 Boehringer Ingelheim Investigational Site
🇳🇴Follebu, Norway
205.389.2765 Boehringer Ingelheim Investigational Site
🇵🇱Bialystok, Poland
205.389.2312 Boehringer Ingelheim Investigational Site
🇱🇻Kuldiga, Latvia
205.389.2304 Boehringer Ingelheim Investigational Site
🇱🇻Valmiera, Latvia
205.389.2410 Boehringer Ingelheim Investigational Site
🇱🇹Utena, Lithuania
205.389.2408 Boehringer Ingelheim Investigational Site
🇱🇹Siauliai, Lithuania
205.389.2413 Boehringer Ingelheim Investigational Site
🇱🇹Vilnius, Lithuania
205.389.2801 Boehringer Ingelheim Investigational Site
🇵🇱Gorzow Wlkp, Poland
205.389.2805 Boehringer Ingelheim Investigational Site
🇵🇱Ilawa, Poland
205.389.2602 Boehringer Ingelheim Investigational Site
🇳🇴Hamar, Norway
205.389.2750 Boehringer Ingelheim Investigational Site
🇵🇱Brzesko, Poland
205.389.2758 Boehringer Ingelheim Investigational Site
🇵🇱Bydgoszcz, Poland
205.389.2773 Boehringer Ingelheim Investigational Site
🇵🇱Bystra, Poland
205.389.2774 Boehringer Ingelheim Investigational Site
🇵🇱Czestochowa, Poland
205.389.2743 Boehringer Ingelheim Investigational Site
🇵🇱Gdansk, Poland
205.389.2800 Boehringer Ingelheim Investigational Site
🇵🇱Chodziez, Poland
205.389.2712 Boehringer Ingelheim Investigational Site
🇵🇱Czestochowa, Poland
205.389.2791 Boehringer Ingelheim Investigational Site
🇵🇱Inowroclaw, Poland
205.389.2787 Boehringer Ingelheim Investigational Site
🇵🇱Elblag, Poland
205.389.2715 Boehringer Ingelheim Investigational Site
🇵🇱Gdansk, Poland
205.389.2802 Boehringer Ingelheim Investigational Site
🇵🇱Gdansk, Poland
205.389.2749 Boehringer Ingelheim Investigational Site
🇵🇱Katowice, Poland
205.389.2759 Boehringer Ingelheim Investigational Site
🇵🇱Koszalin, Poland
205.389.2705 Boehringer Ingelheim Investigational Site
🇵🇱Katowice, Poland
205.389.2771 Boehringer Ingelheim Investigational Site
🇵🇱Katowice, Poland
205.389.2722 Boehringer Ingelheim Investigational Site
🇵🇱Krakow, Poland
205.389.2711 Boehringer Ingelheim Investigational Site
🇵🇱Krakow, Poland
205.389.2753 Boehringer Ingelheim Investigational Site
🇵🇱Krakow, Poland
205.389.2709 Boehringer Ingelheim Investigational Site
🇵🇱Lodz, Poland
205.389.2747 Boehringer Ingelheim Investigational Site
🇵🇱Krakow, Poland
205.389.2757 Boehringer Ingelheim Investigational Site
🇵🇱Kutno, Poland
205.389.2716 Boehringer Ingelheim Investigational Site
🇵🇱Lodz, Poland
205.389.2732 Boehringer Ingelheim Investigational Site
🇵🇱Lodz, Poland
205.389.2702 Boehringer Ingelheim Investigational Site
🇵🇱Ostrow Wielkopolska, Poland
205.389.2795 Boehringer Ingelheim Investigational Site
🇵🇱Plawno, Poland
205.389.2746 Boehringer Ingelheim Investigational Site
🇵🇱Lodz, Poland
205.389.2730 Boehringer Ingelheim Investigational Site
🇵🇱Plock, Poland
205.389.2719 Boehringer Ingelheim Investigational Site
🇵🇱Poznan, Poland
205.389.2737 Boehringer Ingelheim Investigational Site
🇵🇱Poznan, Poland
205.389.2804 Boehringer Ingelheim Investigational Site
🇵🇱Lomza, Poland
205.389.2817 Boehringer Ingelheim Investigational Site
🇵🇱Lublin, Poland
205.389.2813 Boehringer Ingelheim Investigational Site
🇵🇱Poznan, Poland
205.389.2772 Boehringer Ingelheim Investigational Site
🇵🇱Szczecin, Poland
205.389.2734 Boehringer Ingelheim Investigational Site
🇵🇱Warszawa, Poland
205.389.2761 Boehringer Ingelheim Investigational Site
🇵🇱Wroclaw, Poland
205.389.2763 Boehringer Ingelheim Investigational Site
🇵🇱Proszowice, Poland
205.389.2767 Boehringer Ingelheim Investigational Site
🇵🇱Pruszkow, Poland
205.389.2812 Boehringer Ingelheim Investigational Site
🇵🇱Warszawa, Poland
205.389.2792 Boehringer Ingelheim Investigational Site
🇵🇱Sandomierz, Poland
205.389.2738 Boehringer Ingelheim Investigational Site
🇵🇱Tarnow, Poland
205.389.2793 Boehringer Ingelheim Investigational Site
🇵🇱Wroclaw, Poland
205.389.2912 Boehringer Ingelheim Investigational Site
🇵🇹Angra do Heroísmo, Portugal
205.389.2782 Boehringer Ingelheim Investigational Site
🇵🇱Szczecin - Zdunowo, Poland
205.389.2739 Boehringer Ingelheim Investigational Site
🇵🇱Szczecin, Poland
205.389.2799 Boehringer Ingelheim Investigational Site
🇵🇱Tarnow, Poland
205.389.2721 Boehringer Ingelheim Investigational Site
🇵🇱Wroclaw, Poland
205.389.3009 Boehringer Ingelheim Investigational Site
🇷🇴Brasov, Romania
205.389.3018 Boehringer Ingelheim Investigational Site
🇷🇴Brasov, Romania
205.389.3001 Boehringer Ingelheim Investigational Site
🇷🇴Bucuresti, Romania
205.389.2718 Boehringer Ingelheim Investigational Site
🇵🇱Szczecin, Poland
205.389.2707 Boehringer Ingelheim Investigational Site
🇵🇱Warsaw, Poland
205.389.2714 Boehringer Ingelheim Investigational Site
🇵🇱Warsaw, Poland
205.389.2780 Boehringer Ingelheim Investigational Site
🇵🇱Wroclaw, Poland
205.389.2911 Boehringer Ingelheim Investigational Site
🇵🇹Barreiro, Portugal
205.389.2914 Boehringer Ingelheim Investigational Site
🇵🇹Lisboa, Portugal
205.389.3006 Boehringer Ingelheim Investigational Site
🇷🇴Bucuresti, Romania
205.389.3013 Boehringer Ingelheim Investigational Site
🇷🇴Bucuresti, Romania
205.389.3005 Boehringer Ingelheim Investigational Site
🇷🇴Oradea, Romania
205.389.3021 Boehringer Ingelheim Investigational Site
🇷🇴Timisoara, Romania
205.389.3205 Boehringer Ingelheim Investigational Site
🇸🇰Prievidza, Slovakia
205.389.2904 Boehringer Ingelheim Investigational Site
🇵🇹Faro, Portugal
205.389.3025 Boehringer Ingelheim Investigational Site
🇷🇴Bucharest, Romania
205.389.3007 Boehringer Ingelheim Investigational Site
🇷🇴Bucuresti, Romania
205.389.3209 Boehringer Ingelheim Investigational Site
🇸🇰Kosice, Slovakia
205.389.3306 Boehringer Ingelheim Investigational Site
🇸🇮Topolsica, Slovenia
205.389.3514 Boehringer Ingelheim Investigational Site
🇺🇦Donetsk, Ukraine
205.389.2910 Boehringer Ingelheim Investigational Site
🇵🇹Figueira da Foz, Portugal
205.389.2907 Boehringer Ingelheim Investigational Site
🇵🇹Guarda, Portugal
205.389.2905 Boehringer Ingelheim Investigational Site
🇵🇹Santa Maria da Feira, Portugal
205.389.2903 Boehringer Ingelheim Investigational Site
🇵🇹Torres Vedras, Portugal
205.389.3014 Boehringer Ingelheim Investigational Site
🇷🇴Iasi, Romania
205.389.3308 Boehringer Ingelheim Investigational Site
🇸🇮Grosuplje, Slovenia
205.389.3023 Boehringer Ingelheim Investigational Site
🇷🇴Brasov, Romania
205.389.3004 Boehringer Ingelheim Investigational Site
🇷🇴Bucuresti, Romania
205.389.3019 Boehringer Ingelheim Investigational Site
🇷🇴Constanta, Romania
205.389.3015 Boehringer Ingelheim Investigational Site
🇷🇴Craiova, Romania
205.389.3008 Boehringer Ingelheim Investigational Site
🇷🇴Iasi, Romania
205.389.3017 Boehringer Ingelheim Investigational Site
🇷🇴Tg. Mures, Romania
205.389.3204 Boehringer Ingelheim Investigational Site
🇸🇰Kosice, Slovakia
205.389.3210 Boehringer Ingelheim Investigational Site
🇸🇰Revuca, Slovakia
205.389.3302 Boehringer Ingelheim Investigational Site
🇸🇮Kamnik, Slovenia
205.389.3203 Boehringer Ingelheim Investigational Site
🇸🇰Spisska Nova Ves, Slovakia
205.389.3303 Boehringer Ingelheim Investigational Site
🇸🇮Ljubljana, Slovenia
205.389.3521 Boehringer Ingelheim Investigational Site
🇺🇦AR Crimea, Ukraine
205.389.3522 Boehringer Ingelheim Investigational Site
🇺🇦Kharkiv, Ukraine
205.389.3532 Boehringer Ingelheim Investigational Site
🇺🇦Kharkiv, Ukraine
205.389.3541 Boehringer Ingelheim Investigational Site
🇺🇦Kharkiv, Ukraine
205.389.3509 Boehringer Ingelheim Investigational Site
🇺🇦Dnipropetrovsk, Ukraine
205.389.3524 Boehringer Ingelheim Investigational Site
🇺🇦Donetsk, Ukraine
205.389.3507 Boehringer Ingelheim Investigational Site
🇺🇦Kharkiv, Ukraine
205.389.3508 Boehringer Ingelheim Investigational Site
🇺🇦Kharkiv, Ukraine
205.389.3543 Boehringer Ingelheim Investigational Site
🇺🇦Kharkiv, Ukraine
205.389.3547 Boehringer Ingelheim Investigational Site
🇺🇦Zaporizhzhya, Ukraine
205.389.3539 Boehringer Ingelheim Investigational Site
🇺🇦Kharkiv, Ukraine
205.389.3502 Boehringer Ingelheim Investigational Site
🇺🇦Kiev, Ukraine
205.389.3538 Boehringer Ingelheim Investigational Site
🇺🇦Kyiv, Ukraine
205.389.3519 Boehringer Ingelheim Investigational Site
🇺🇦Odesa, Ukraine
205.389.3503 Boehringer Ingelheim Investigational Site
🇺🇦Kiev, Ukraine
205.389.3528 Boehringer Ingelheim Investigational Site
🇺🇦Kyiv, Ukraine
205.389.3542 Boehringer Ingelheim Investigational Site
🇺🇦Odesa, Ukraine
205.389.3517 Boehringer Ingelheim Investigational Site
🇺🇦Simferopil, Ukraine
205.389.3536 Boehringer Ingelheim Investigational Site
🇺🇦Kyiv, Ukraine
205.389.3515 Boehringer Ingelheim Investigational Site
🇺🇦Zaporizhzhya, Ukraine
205.389.3551 Boehringer Ingelheim Investigational Site
🇺🇦Kyiv, Ukraine
205.389.3513 Boehringer Ingelheim Investigational Site
🇺🇦m.Odesa, Ukraine
205.389.3527 Boehringer Ingelheim Investigational Site
🇺🇦Odessa, Ukraine
205.389.3531 Boehringer Ingelheim Investigational Site
🇺🇦Poltava, Ukraine
205.389.2754 Boehringer Ingelheim Investigational Site
🇵🇱Tranow, Poland
205.389.1016 Boehringer Ingelheim Investigational Site
🇦🇹Spittal/Drau, Austria
205.389.1001 Boehringer Ingelheim Investigational Site
🇦🇹Mittersill, Austria
205.389.1022 Boehringer Ingelheim Investigational Site
🇦🇹Steyr, Austria
205.389.1023 Boehringer Ingelheim Investigational Site
🇦🇹Linz, Austria
205.389.1113 Boehringer Ingelheim Investigational Site
🇧🇪Gembloux, Belgium
205.389.1121 Boehringer Ingelheim Investigational Site
🇧🇪Dour, Belgium
205.389.1129 Boehringer Ingelheim Investigational Site
🇧🇪Natoye, Belgium
205.389.1115 Boehringer Ingelheim Investigational Site
🇧🇪Thuillies, Belgium
205.389.3911 Boehringer Ingelheim Investigational Site
🇧🇬Pazardjik, Bulgaria
205.389.3918 Boehringer Ingelheim Investigational Site
🇧🇬Rousse, Bulgaria
205.389.3902 Boehringer Ingelheim Investigational Site
🇧🇬Sofia, Bulgaria
205.389.1120 Boehringer Ingelheim Investigational Site
🇧🇪Buizingen, Belgium
205.389.1124 Boehringer Ingelheim Investigational Site
🇧🇪Cerexhe Heuseux, Belgium
205.389.1126 Boehringer Ingelheim Investigational Site
🇧🇪Hasselt, Belgium
205.389.1107 Boehringer Ingelheim Investigational Site
🇧🇪Wetteren, Belgium
205.389.1301 Boehringer Ingelheim Investigational Site
🇩🇰Helsingor, Denmark
205.389.1017 Boehringer Ingelheim Investigational Site
🇦🇹Zwettl, Austria
205.389.1117 Boehringer Ingelheim Investigational Site
🇧🇪Gozée, Belgium
205.389.3914 Boehringer Ingelheim Investigational Site
🇧🇬Sliven, Bulgaria
205.389.1790 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.3903 Boehringer Ingelheim Investigational Site
🇧🇬Plovdiv, Bulgaria
205.389.3915 Boehringer Ingelheim Investigational Site
🇧🇬Plovdiv, Bulgaria
205.389.1029 Boehringer Ingelheim Investigational Site
🇦🇹Wien, Austria
205.389.1116 Boehringer Ingelheim Investigational Site
🇧🇪Chenée (Liége), Belgium
205.389.1507 Boehringer Ingelheim Investigational Site
🇫🇷Cholet, France
205.389.3912 Boehringer Ingelheim Investigational Site
🇧🇬Varna, Bulgaria
205.389.1525 Boehringer Ingelheim Investigational Site
🇫🇷Beauvais, France
205.389.3907 Boehringer Ingelheim Investigational Site
🇧🇬Sofia, Bulgaria
205.389.1581 Boehringer Ingelheim Investigational Site
🇫🇷La Jubaudière, France
205.389.1536 Boehringer Ingelheim Investigational Site
🇫🇷La Roche Sur Yon, France
205.389.3906 Boehringer Ingelheim Investigational Site
🇧🇬Sofia, Bulgaria
205.389.1571 Boehringer Ingelheim Investigational Site
🇫🇷Cestas, France
205.389.3916 Boehringer Ingelheim Investigational Site
🇧🇬Troyan, Bulgaria
205.389.1302 Boehringer Ingelheim Investigational Site
🇩🇰Næstved, Denmark
205.389.1501 Boehringer Ingelheim Investigational Site
🇫🇷Le Kremlin Bicetre, France
205.389.1554 Boehringer Ingelheim Investigational Site
🇫🇷Ermont, France
205.389.1569 Boehringer Ingelheim Investigational Site
🇫🇷Seysses, France
205.389.1598 Boehringer Ingelheim Investigational Site
🇫🇷La Roche sur Yon, France
205.389.1726 Boehringer Ingelheim Investigational Site
🇩🇪Ingelheim, Germany
205.389.1789 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1607 Boehringer Ingelheim Investigational Site
🇫🇷Bauge, France
205.389.1868 Boehringer Ingelheim Investigational Site
🇩🇪Augsburg, Germany
205.389.1750 Boehringer Ingelheim Investigational Site
🇩🇪Berkatal-Frankershausen, Germany
205.389.1707 Boehringer Ingelheim Investigational Site
🇩🇪Bad Lippspringe, Germany
205.389.1722 Boehringer Ingelheim Investigational Site
🇩🇪Bad Pymont, Germany
205.389.1709 Boehringer Ingelheim Investigational Site
🇩🇪Bergkamen, Germany
205.389.1532 Boehringer Ingelheim Investigational Site
🇫🇷PIERRE BENITE cédex, France
205.389.1743 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1903 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1773 Boehringer Ingelheim Investigational Site
🇩🇪Ense, Germany
205.389.1808 Boehringer Ingelheim Investigational Site
🇩🇪Bochum, Germany
205.389.1859 Boehringer Ingelheim Investigational Site
🇩🇪Bruchsal, Germany
205.389.1713 Boehringer Ingelheim Investigational Site
🇩🇪Dortmund, Germany
205.389.1503 Boehringer Ingelheim Investigational Site
🇫🇷Le Mans Cedex, France
205.389.1586 Boehringer Ingelheim Investigational Site
🇫🇷Le Pradet, France
205.389.1769 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1855 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1792 Boehringer Ingelheim Investigational Site
🇩🇪Beckum, Germany
205.389.1934 Boehringer Ingelheim Investigational Site
🇩🇪Auerbach, Germany
205.389.1946 Boehringer Ingelheim Investigational Site
🇩🇪Bensheim, Germany
205.389.1741 Boehringer Ingelheim Investigational Site
🇩🇪Aachen, Germany
205.389.1542 Boehringer Ingelheim Investigational Site
🇫🇷Toulouse, France
205.389.1864 Boehringer Ingelheim Investigational Site
🇩🇪Erfurt, Germany
205.389.1705 Boehringer Ingelheim Investigational Site
🇩🇪Borna, Germany
205.389.1702 Boehringer Ingelheim Investigational Site
🇩🇪Hammelburg, Germany
205.389.1886 Boehringer Ingelheim Investigational Site
🇩🇪Greiz, Germany
205.389.1984 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1744 Boehringer Ingelheim Investigational Site
🇩🇪Georgensgmünd, Germany
205.389.1924 Boehringer Ingelheim Investigational Site
🇩🇪Hamburg, Germany
205.389.1811 Boehringer Ingelheim Investigational Site
🇩🇪Bochum, Germany
205.389.1828 Boehringer Ingelheim Investigational Site
🇩🇪Bonn, Germany
205.389.1870 Boehringer Ingelheim Investigational Site
🇩🇪Bonn, Germany
205.389.1976 Boehringer Ingelheim Investigational Site
🇩🇪Forchheim, Germany
205.389.1949 Boehringer Ingelheim Investigational Site
🇩🇪Höchstädt, Germany
205.389.1704 Boehringer Ingelheim Investigational Site
🇩🇪Käbschütztal-Krögis, Germany
205.389.1751 Boehringer Ingelheim Investigational Site
🇩🇪Göttingen, Germany
205.389.1971 Boehringer Ingelheim Investigational Site
🇩🇪Fürth, Germany
205.389.1905 Boehringer Ingelheim Investigational Site
🇩🇪Frankfurt/Main, Germany
205.389.1975 Boehringer Ingelheim Investigational Site
🇩🇪Essen, Germany
205.389.2035 Boehringer Ingelheim Investigational Site
🇭🇺Deszk, Hungary
205.389.1813 Boehringer Ingelheim Investigational Site
🇩🇪Köthen, Germany
205.389.1908 Boehringer Ingelheim Investigational Site
🇩🇪Leipzig, Germany
205.389.1874 Boehringer Ingelheim Investigational Site
🇩🇪Leonberg, Germany
205.389.2006 Boehringer Ingelheim Investigational Site
🇭🇺Budapest, Hungary
205.389.1866 Boehringer Ingelheim Investigational Site
🇩🇪Marburg, Germany
205.389.1879 Boehringer Ingelheim Investigational Site
🇩🇪Magdeburg, Germany
205.389.1776 Boehringer Ingelheim Investigational Site
🇩🇪Marl, Germany
205.389.2014 Boehringer Ingelheim Investigational Site
🇭🇺Jászberény, Hungary
205.389.2011 Boehringer Ingelheim Investigational Site
🇭🇺Füzesabony, Hungary
205.389.2018 Boehringer Ingelheim Investigational Site
🇭🇺Budapest, Hungary
205.389.2007 Boehringer Ingelheim Investigational Site
🇭🇺Debrecen, Hungary
205.389.2031 Boehringer Ingelheim Investigational Site
🇭🇺Nyíregyháza, Hungary
205.389.1926 Boehringer Ingelheim Investigational Site
🇩🇪Marburg, Germany
205.389.1779 Boehringer Ingelheim Investigational Site
🇩🇪Merrbusch, Germany
205.389.2005 Boehringer Ingelheim Investigational Site
🇭🇺Budapest, Hungary
205.389.1815 Boehringer Ingelheim Investigational Site
🇩🇪München, Germany
205.389.1817 Boehringer Ingelheim Investigational Site
🇩🇪München, Germany
205.389.2028 Boehringer Ingelheim Investigational Site
🇭🇺Gyula, Hungary
205.389.1840 Boehringer Ingelheim Investigational Site
🇩🇪Mannheim, Germany
205.389.2001 Boehringer Ingelheim Investigational Site
🇭🇺Budapest, Hungary
205.389.2016 Boehringer Ingelheim Investigational Site
🇭🇺Budapest, Hungary
205.389.1871 Boehringer Ingelheim Investigational Site
🇩🇪Marburg, Germany
205.389.1842 Boehringer Ingelheim Investigational Site
🇩🇪Radebeul, Germany
205.389.1978 Boehringer Ingelheim Investigational Site
🇩🇪Mannheim, Germany
205.389.2013 Boehringer Ingelheim Investigational Site
🇭🇺Gyor, Hungary
205.389.2025 Boehringer Ingelheim Investigational Site
🇭🇺Komárom, Hungary
205.389.1952 Boehringer Ingelheim Investigational Site
🇩🇪Neubrandenburg, Germany
205.389.1843 Boehringer Ingelheim Investigational Site
🇩🇪München, Germany
205.389.2407 Boehringer Ingelheim Investigational Site
🇱🇹Klaipeda, Lithuania
205.389.2614 Boehringer Ingelheim Investigational Site
🇳🇴Alesund, Norway
205.389.2504 Boehringer Ingelheim Investigational Site
🇳🇱Rotterdam, Netherlands
205.389.2508 Boehringer Ingelheim Investigational Site
🇳🇱te Leiderdrop, Netherlands
205.389.2302 Boehringer Ingelheim Investigational Site
🇱🇻Ventspils, Latvia
205.389.2402 Boehringer Ingelheim Investigational Site
🇱🇹Kaunas, Lithuania
205.389.2403 Boehringer Ingelheim Investigational Site
🇱🇹Kaunas, Lithuania
205.389.2744 Boehringer Ingelheim Investigational Site
🇵🇱Bialystok, Poland
205.389.2701 Boehringer Ingelheim Investigational Site
🇵🇱Lodz, Poland
205.389.2751 Boehringer Ingelheim Investigational Site
🇵🇱Lodz, Poland
205.389.2766 Boehringer Ingelheim Investigational Site
🇵🇱Poznan, Poland
205.389.2768 Boehringer Ingelheim Investigational Site
🇵🇱Radom, Poland
205.389.2781 Boehringer Ingelheim Investigational Site
🇵🇱Sieradz, Poland
205.389.2725 Boehringer Ingelheim Investigational Site
🇵🇱Skierniewice, Poland
205.389.2736 Boehringer Ingelheim Investigational Site
🇵🇱Wroclaw, Poland
205.389.2770 Boehringer Ingelheim Investigational Site
🇵🇱Zgierz, Poland
205.389.3116 Boehringer Ingelheim Investigational Site
🇷🇺Ekaterinburg, Russian Federation
205.389.3105 Boehringer Ingelheim Investigational Site
🇷🇺Chelyabinsk, Russian Federation
205.389.2803 Boehringer Ingelheim Investigational Site
🇵🇱Wabrzenzo, Poland
205.389.2806 Boehringer Ingelheim Investigational Site
🇵🇱Turek, Poland
205.389.2728 Boehringer Ingelheim Investigational Site
🇵🇱Warsaw, Poland
205.389.2818 Boehringer Ingelheim Investigational Site
🇵🇱Warszawa, Poland
205.389.2731 Boehringer Ingelheim Investigational Site
🇵🇱Wroclaw, Poland
205.389.2752 Boehringer Ingelheim Investigational Site
🇵🇱Wroclaw, Poland
205.389.2783 Boehringer Ingelheim Investigational Site
🇵🇱Zabrze, Poland
205.389.2735 Boehringer Ingelheim Investigational Site
🇵🇱Zakopane, Poland
205.389.3113 Boehringer Ingelheim Investigational Site
🇷🇺Barnaul, Russian Federation
205.389.3131 Boehringer Ingelheim Investigational Site
🇷🇺Barnaul, Russian Federation
205.389.3024 Boehringer Ingelheim Investigational Site
🇷🇴Iasi, Romania
205.389.3149 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3184 Boehringer Ingelheim Investigational Site
🇷🇺Chelyabinsk, Russian Federation
205.389.3167 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3106 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3156 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3125 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3136 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3157 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3153 Boehringer Ingelheim Investigational Site
🇷🇺Novosibirsk, Russian Federation
205.389.3175 Boehringer Ingelheim Investigational Site
🇷🇺Novosibirsk, Russian Federation
205.389.3164 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3168 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3171 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3195 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3180 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3147 Boehringer Ingelheim Investigational Site
🇷🇺St.Petersburg, Russian Federation
205.389.3189 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3165 Boehringer Ingelheim Investigational Site
🇷🇺St.Peterburg, Russian Federation
205.389.3501 Boehringer Ingelheim Investigational Site
🇺🇦Kiev, Ukraine
205.389.3550 Boehringer Ingelheim Investigational Site
🇺🇦Kiev, Ukraine
205.389.3639 Boehringer Ingelheim Investigational Site
🇬🇧Frome, United Kingdom
205.389.1304 Boehringer Ingelheim Investigational Site
🇩🇰Copenhagen, Denmark
205.389.1309 Boehringer Ingelheim Investigational Site
🇩🇰Frederikssund, Denmark
205.389.1308 Boehringer Ingelheim Investigational Site
🇩🇰Helsingør, Denmark
205.389.1311 Boehringer Ingelheim Investigational Site
🇩🇰Holstebro, Denmark
205.389.1310 Boehringer Ingelheim Investigational Site
🇩🇰Skive, Denmark
205.389.1312 Boehringer Ingelheim Investigational Site
🇩🇰Sonderborg, Denmark
205.389.1307 Boehringer Ingelheim Investigational Site
🇩🇰Værløse, Denmark
205.389.1523 Boehringer Ingelheim Investigational Site
🇫🇷Bethune, France
205.389.1561 Boehringer Ingelheim Investigational Site
🇫🇷Charry le Rouet, France
205.389.1528 Boehringer Ingelheim Investigational Site
🇫🇷Marseille, France
205.389.1526 Boehringer Ingelheim Investigational Site
🇫🇷Nice, France
205.389.1539 Boehringer Ingelheim Investigational Site
🇫🇷Montfermeil, France
205.389.1608 Boehringer Ingelheim Investigational Site
🇫🇷Nantes, France
205.389.1504 Boehringer Ingelheim Investigational Site
🇫🇷Nimes, France
205.389.1541 Boehringer Ingelheim Investigational Site
🇫🇷Orleans, France
205.389.1502 Boehringer Ingelheim Investigational Site
🇫🇷Ollioules, France
205.389.1527 Boehringer Ingelheim Investigational Site
🇫🇷Perpignan, France
205.389.1553 Boehringer Ingelheim Investigational Site
🇫🇷Rennes cedex 9, France
205.389.1575 Boehringer Ingelheim Investigational Site
🇫🇷Saint Germain du Puch, France
205.389.1547 Boehringer Ingelheim Investigational Site
🇫🇷Saint Laurent du Var, France
205.389.1567 Boehringer Ingelheim Investigational Site
🇫🇷Saint Orens de Cameville, France
205.389.1577 Boehringer Ingelheim Investigational Site
🇫🇷Saint Pierre Montlimard, France
205.389.1531 Boehringer Ingelheim Investigational Site
🇫🇷Saint Quentin, France
205.389.1514 Boehringer Ingelheim Investigational Site
🇫🇷St-Etienne, France
205.389.1510 Boehringer Ingelheim Investigational Site
🇫🇷Strasbourg, France
205.389.1520 Boehringer Ingelheim Investigational Site
🇫🇷Sélestat, France
205.389.1574 Boehringer Ingelheim Investigational Site
🇫🇷Villenave D'ornon, France
205.389.3812 Boehringer Ingelheim Investigational Site
🇹🇷Istanbul, Turkey
205.389.3636 Boehringer Ingelheim Investigational Site
🇬🇧Bexhill-on-Sea, United Kingdom
205.389.3608 Boehringer Ingelheim Investigational Site
🇬🇧Birmingham, United Kingdom
205.389.3609 Boehringer Ingelheim Investigational Site
🇬🇧Bolton, United Kingdom
205.389.3606 Boehringer Ingelheim Investigational Site
🇬🇧Coventry, United Kingdom
205.389.3633 Boehringer Ingelheim Investigational Site
🇬🇧Coventry, United Kingdom
205.389.3622 Boehringer Ingelheim Investigational Site
🇬🇧Radstock, United Kingdom
205.389.3624 Boehringer Ingelheim Investigational Site
🇬🇧Sunderland, United Kingdom
205.389.3613 Boehringer Ingelheim Investigational Site
🇬🇧St Just, Penzance, United Kingdom
205.389.3626 Boehringer Ingelheim Investigational Site
🇬🇧Randalstown, United Kingdom
205.389.3138 Boehringer Ingelheim Investigational Site
🇷🇺Ekaterinburg, Russian Federation
205.389.3182 Boehringer Ingelheim Investigational Site
🇷🇺Chelyabinsk, Russian Federation
205.389.3183 Boehringer Ingelheim Investigational Site
🇷🇺Chelyabinsk, Russian Federation
205.389.3166 Boehringer Ingelheim Investigational Site
🇷🇺Ekaterinburg, Russian Federation
205.389.3103 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3111 Boehringer Ingelheim Investigational Site
🇷🇺Kemerovo, Russian Federation
205.389.3170 Boehringer Ingelheim Investigational Site
🇷🇺Krasnodar, Russian Federation
205.389.3193 Boehringer Ingelheim Investigational Site
🇷🇺Kaliningrad, Russian Federation
205.389.3120 Boehringer Ingelheim Investigational Site
🇷🇺Kirov, Russian Federation
205.389.3127 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3128 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3143 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3151 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3163 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3112 Boehringer Ingelheim Investigational Site
🇷🇺Novosibirsk, Russian Federation
205.389.3126 Boehringer Ingelheim Investigational Site
🇷🇺Orenburg, Russian Federation
205.389.3114 Boehringer Ingelheim Investigational Site
🇷🇺Novosibirsk, Russian Federation
205.389.3129 Boehringer Ingelheim Investigational Site
🇷🇺Novosibirsk, Russian Federation
205.389.3141 Boehringer Ingelheim Investigational Site
🇷🇺Novosibirsk, Russian Federation
205.389.3185 Boehringer Ingelheim Investigational Site
🇷🇺Perm, Russian Federation
205.389.3199 Boehringer Ingelheim Investigational Site
🇷🇺Pyatigorsk,, Russian Federation
205.389.3159 Boehringer Ingelheim Investigational Site
🇷🇺Rostov-on-Don, Russian Federation
205.389.3197 Boehringer Ingelheim Investigational Site
🇷🇺Ryazan, Russian Federation
205.389.3192 Boehringer Ingelheim Investigational Site
🇷🇺Petrozavodsk, Russian Federation
205.389.3190 Boehringer Ingelheim Investigational Site
🇷🇺Pskov, Russian Federation
205.389.3198 Boehringer Ingelheim Investigational Site
🇷🇺Saint Petersburg, Russian Federation
205.389.3191 Boehringer Ingelheim Investigational Site
🇷🇺St-Petersburg, Russian Federation
205.389.3119 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3121 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3122 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3135 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3137 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3145 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3146 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3177 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3181 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3117 Boehringer Ingelheim Investigational Site
🇷🇺St.Petersburg, Russian Federation
205.389.3152 Boehringer Ingelheim Investigational Site
🇷🇺St.Petersburg, Russian Federation
205.389.3118 Boehringer Ingelheim Investigational Site
🇷🇺Yaroslavl, Russian Federation
205.389.3901 Boehringer Ingelheim Investigational Site
🇧🇬Veliko Turnovo, Bulgaria
205.389.1887 Boehringer Ingelheim Investigational Site
🇩🇪Augsburg, Germany
205.389.1824 Boehringer Ingelheim Investigational Site
🇩🇪Bergisch Gladbach, Germany
205.389.1701 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1847 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1862 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1932 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1960 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1983 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1809 Boehringer Ingelheim Investigational Site
🇩🇪Brandenburg/Havel, Germany
205.389.1901 Boehringer Ingelheim Investigational Site
🇩🇪Coswig, Germany
205.389.1891 Boehringer Ingelheim Investigational Site
🇩🇪Cottbus, Germany
205.389.1923 Boehringer Ingelheim Investigational Site
🇩🇪Celle, Germany
205.389.1967 Boehringer Ingelheim Investigational Site
🇩🇪Düren, Germany
205.389.1706 Boehringer Ingelheim Investigational Site
🇩🇪Dresden, Germany
205.389.1814 Boehringer Ingelheim Investigational Site
🇩🇪Engelskirchen, Germany
205.389.1900 Boehringer Ingelheim Investigational Site
🇩🇪Eschwege, Germany
205.389.1982 Boehringer Ingelheim Investigational Site
🇩🇪Essen, Germany
205.389.1727 Boehringer Ingelheim Investigational Site
🇩🇪Eppelborn-Bubach, Germany
205.389.1940 Boehringer Ingelheim Investigational Site
🇩🇪Erlangen, Germany
205.389.1724 Boehringer Ingelheim Investigational Site
🇩🇪Ettlingen, Germany
205.389.1752 Boehringer Ingelheim Investigational Site
🇩🇪Fuldatal-Ihringshausen, Germany
205.389.1766 Boehringer Ingelheim Investigational Site
🇩🇪Gars, Germany
205.389.1875 Boehringer Ingelheim Investigational Site
🇩🇪Gießen, Germany
205.389.1977 Boehringer Ingelheim Investigational Site
🇩🇪Gelsenkirchen, Germany
205.389.1914 Boehringer Ingelheim Investigational Site
🇩🇪Goch, Germany
205.389.1836 Boehringer Ingelheim Investigational Site
🇩🇪Gifhorn, Germany
205.389.1831 Boehringer Ingelheim Investigational Site
🇩🇪Hagen, Germany
205.389.1768 Boehringer Ingelheim Investigational Site
🇩🇪Grünberg, Germany
205.389.1827 Boehringer Ingelheim Investigational Site
🇩🇪Halle, Germany
205.389.1802 Boehringer Ingelheim Investigational Site
🇩🇪Hannover, Germany
205.389.1917 Boehringer Ingelheim Investigational Site
🇩🇪Hamburg, Germany
205.389.1925 Boehringer Ingelheim Investigational Site
🇩🇪Hamburg, Germany
205.389.1712 Boehringer Ingelheim Investigational Site
🇩🇪Harsewinkel, Germany
205.389.1980 Boehringer Ingelheim Investigational Site
🇩🇪Hamburg, Germany
205.389.1738 Boehringer Ingelheim Investigational Site
🇩🇪Hauzenberg, Germany
205.389.1873 Boehringer Ingelheim Investigational Site
🇩🇪Karlsruhe, Germany
205.389.1786 Boehringer Ingelheim Investigational Site
🇩🇪Krumpa, Germany
205.389.1838 Boehringer Ingelheim Investigational Site
🇩🇪Kaufbeuren, Germany
205.389.1892 Boehringer Ingelheim Investigational Site
🇩🇪Köln, Germany
205.389.1839 Boehringer Ingelheim Investigational Site
🇩🇪Koblenz, Germany
205.389.1974 Boehringer Ingelheim Investigational Site
🇩🇪Köln, Germany
205.389.1948 Boehringer Ingelheim Investigational Site
🇩🇪Neuss, Germany
205.389.1830 Boehringer Ingelheim Investigational Site
🇩🇪Niesky, Germany
205.389.1955 Boehringer Ingelheim Investigational Site
🇩🇪Limburg, Germany
205.389.1711 Boehringer Ingelheim Investigational Site
🇩🇪Nussbach, Germany
205.389.1904 Boehringer Ingelheim Investigational Site
🇩🇪Lorch, Germany
205.389.1958 Boehringer Ingelheim Investigational Site
🇩🇪Neuwied, Germany
205.389.1805 Boehringer Ingelheim Investigational Site
🇩🇪Neuötting, Germany
205.389.1877 Boehringer Ingelheim Investigational Site
🇩🇪Lübeck, Germany
205.389.1756 Boehringer Ingelheim Investigational Site
🇩🇪Pirmasens, Germany
205.389.1781 Boehringer Ingelheim Investigational Site
🇩🇪Oberdorla, Germany
205.389.1753 Boehringer Ingelheim Investigational Site
🇩🇪Paderborn, Germany
205.389.1794 Boehringer Ingelheim Investigational Site
🇩🇪Potsdam, Germany
205.389.1899 Boehringer Ingelheim Investigational Site
🇩🇪Potsdam, Germany
205.389.1897 Boehringer Ingelheim Investigational Site
🇩🇪Rathenow, Germany
205.389.1950 Boehringer Ingelheim Investigational Site
🇩🇪Raubach, Germany
205.389.1816 Boehringer Ingelheim Investigational Site
🇩🇪Rüdersdorf, Germany
205.389.1826 Boehringer Ingelheim Investigational Site
🇩🇪Riesa, Germany
205.389.1878 Boehringer Ingelheim Investigational Site
🇩🇪Saarlouis, Germany
205.389.1883 Boehringer Ingelheim Investigational Site
🇩🇪Rüsselsheim, Germany
205.389.1833 Boehringer Ingelheim Investigational Site
🇩🇪Schmallenberg-Grafschaft, Germany
205.389.1973 Boehringer Ingelheim Investigational Site
🇩🇪Schmölln, Germany
205.389.1979 Boehringer Ingelheim Investigational Site
🇩🇪Schwetzingen, Germany
205.389.1728 Boehringer Ingelheim Investigational Site
🇩🇪Sulzbach, Germany
205.389.1856 Boehringer Ingelheim Investigational Site
🇩🇪Simmern, Germany
205.389.1918 Boehringer Ingelheim Investigational Site
🇩🇪Solingen, Germany
205.389.1822 Boehringer Ingelheim Investigational Site
🇩🇪Steinfurt, Germany
205.389.1717 Boehringer Ingelheim Investigational Site
🇩🇪Templin, Germany
205.389.1882 Boehringer Ingelheim Investigational Site
🇩🇪Treuenbrietzen, Germany
205.389.1885 Boehringer Ingelheim Investigational Site
🇩🇪Weißenhorn, Germany
205.389.1863 Boehringer Ingelheim Investigational Site
🇩🇪Wiesbaden, Germany
205.389.1968 Boehringer Ingelheim Investigational Site
🇩🇪Wilhelmshaven, Germany
205.389.1927 Boehringer Ingelheim Investigational Site
🇩🇪Westerstede, Germany
205.389.1807 Boehringer Ingelheim Investigational Site
🇩🇪Wilster, Germany
205.389.1754 Boehringer Ingelheim Investigational Site
🇩🇪Wolfsburg, Germany
205.389.1919 Boehringer Ingelheim Investigational Site
🇩🇪Wuppertal, Germany
205.389.3107 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3108 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3196 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.1005 Boehringer Ingelheim Investigational Site
🇦🇹Hallein, Austria
205.389.1515 Boehringer Ingelheim Investigational Site
🇫🇷Toulon, France
205.389.1519 Boehringer Ingelheim Investigational Site
🇫🇷Toulon, France
205.389.1512 Boehringer Ingelheim Investigational Site
🇫🇷Toulon, France
205.389.1588 Boehringer Ingelheim Investigational Site
🇫🇷Toulon, France
205.389.1589 Boehringer Ingelheim Investigational Site
🇫🇷Toulon, France
205.389.1590 Boehringer Ingelheim Investigational Site
🇫🇷Toulon, France
205.389.1810 Boehringer Ingelheim Investigational Site
🇩🇪Paderborn, Germany
205.389.1854 Boehringer Ingelheim Investigational Site
🇩🇪Paderborn, Germany
205.389.1800 Boehringer Ingelheim Investigational Site
🇩🇪Wardenburg, Germany
205.389.1745 Boehringer Ingelheim Investigational Site
🇩🇪Wallerfing, Germany
205.389.1765 Boehringer Ingelheim Investigational Site
🇩🇪Bahrdorf, Germany
205.389.1010 Boehringer Ingelheim Investigational Site
🇦🇹Feldkirch, Austria
205.389.1003 Boehringer Ingelheim Investigational Site
🇦🇹Gänserndorf, Austria
205.389.1011 Boehringer Ingelheim Investigational Site
🇦🇹Grimmenstein/Hochegg, Austria
205.389.1026 Boehringer Ingelheim Investigational Site
🇦🇹Schlüßlberg, Austria
205.389.3908 Boehringer Ingelheim Investigational Site
🇧🇬Stara Zagora, Bulgaria
205.389.1213 Boehringer Ingelheim Investigational Site
🇨🇿Beroun, Czech Republic
205.389.1225 Boehringer Ingelheim Investigational Site
🇨🇿Liberec, Czech Republic
205.389.1215 Boehringer Ingelheim Investigational Site
🇨🇿Praha 17, Czech Republic
205.389.1223 Boehringer Ingelheim Investigational Site
🇨🇿Praha 5, Czech Republic
205.389.1206 Boehringer Ingelheim Investigational Site
🇨🇿Tremosna, Czech Republic
205.389.1303 Boehringer Ingelheim Investigational Site
🇩🇰Roskilde, Denmark
205.389.1402 Boehringer Ingelheim Investigational Site
🇫🇮Helsinki, Finland
205.389.1412 Boehringer Ingelheim Investigational Site
🇫🇮Preitilä Paimio, Finland
205.389.1410 Boehringer Ingelheim Investigational Site
🇫🇮Jyväskylä, Finland
205.389.1606 Boehringer Ingelheim Investigational Site
🇫🇷Ecouflant, France
205.389.1597 Boehringer Ingelheim Investigational Site
🇫🇷La Barre de Monts, France
205.389.1558 Boehringer Ingelheim Investigational Site
🇫🇷Marseille, France
205.389.1530 Boehringer Ingelheim Investigational Site
🇫🇷Marseille, France
205.389.1564 Boehringer Ingelheim Investigational Site
🇫🇷Marseille, France
205.389.1565 Boehringer Ingelheim Investigational Site
🇫🇷Marseille, France
205.389.1555 Boehringer Ingelheim Investigational Site
🇫🇷Saint Dié des Vosges, France
205.389.1572 Boehringer Ingelheim Investigational Site
🇫🇷Saint Laurent, France
205.389.1522 Boehringer Ingelheim Investigational Site
🇫🇷Strasbourg, France
205.389.1595 Boehringer Ingelheim Investigational Site
🇫🇷Toulon, France
205.389.1857 Boehringer Ingelheim Investigational Site
🇩🇪Aalen, Germany
205.389.1969 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1850 Boehringer Ingelheim Investigational Site
🇩🇪Bad Wörishofen, Germany
205.389.1801 Boehringer Ingelheim Investigational Site
🇩🇪Bensheim, Germany
205.389.1867 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1981 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1937 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1747 Boehringer Ingelheim Investigational Site
🇩🇪Bocholt, Germany
205.389.1734 Boehringer Ingelheim Investigational Site
🇩🇪Camburg, Germany
205.389.1858 Boehringer Ingelheim Investigational Site
🇩🇪Deggendorf, Germany
205.389.1784 Boehringer Ingelheim Investigational Site
🇩🇪Donaueschingen, Germany
205.389.1758 Boehringer Ingelheim Investigational Site
🇩🇪Essen, Germany
205.389.1806 Boehringer Ingelheim Investigational Site
🇩🇪Feldkirchen-Westerham, Germany
205.389.1943 Boehringer Ingelheim Investigational Site
🇩🇪Föhren, Germany
205.389.1795 Boehringer Ingelheim Investigational Site
🇩🇪Frankenberg, Germany
205.389.1716 Boehringer Ingelheim Investigational Site
🇩🇪Hammah, Germany
205.389.1860 Boehringer Ingelheim Investigational Site
🇩🇪Hemmingen, Germany
205.389.1902 Boehringer Ingelheim Investigational Site
🇩🇪Landsberg, Germany
205.389.1841 Boehringer Ingelheim Investigational Site
🇩🇪Leipzig, Germany
205.389.1837 Boehringer Ingelheim Investigational Site
🇩🇪Leipzig, Germany
205.389.1881 Boehringer Ingelheim Investigational Site
🇩🇪Krefeld, Germany
205.389.1823 Boehringer Ingelheim Investigational Site
🇩🇪Lützen, Germany
205.389.1894 Boehringer Ingelheim Investigational Site
🇩🇪Leipzig, Germany
205.389.1799 Boehringer Ingelheim Investigational Site
🇩🇪München, Germany
205.389.1783 Boehringer Ingelheim Investigational Site
🇩🇪Riesa, Germany
205.389.1742 Boehringer Ingelheim Investigational Site
🇩🇪Rostock, Germany
205.389.1825 Boehringer Ingelheim Investigational Site
🇩🇪Weyhe, Germany
205.389.1898 Boehringer Ingelheim Investigational Site
🇩🇪Zerbst, Germany
205.389.2009 Boehringer Ingelheim Investigational Site
🇭🇺Budapest, Hungary
205.389.2015 Boehringer Ingelheim Investigational Site
🇭🇺Dunaújváros, Hungary
205.389.2024 Boehringer Ingelheim Investigational Site
🇭🇺Mosdós, Hungary
205.389.2021 Boehringer Ingelheim Investigational Site
🇭🇺Kecskemét, Hungary
205.389.2026 Boehringer Ingelheim Investigational Site
🇭🇺Mosonmagyaróvár, Hungary
205.389.2002 Boehringer Ingelheim Investigational Site
🇭🇺Pécs, Hungary
205.389.2017 Boehringer Ingelheim Investigational Site
🇭🇺Ráckeve, Hungary
205.389.2003 Boehringer Ingelheim Investigational Site
🇭🇺Siófok, Hungary
205.389.2010 Boehringer Ingelheim Investigational Site
🇭🇺Szarvas, Hungary
205.389.2019 Boehringer Ingelheim Investigational Site
🇭🇺Szentendre, Hungary
205.389.2022 Boehringer Ingelheim Investigational Site
🇭🇺Százhalombatta, Hungary
205.389.2030 Boehringer Ingelheim Investigational Site
🇭🇺Tatabánya, Hungary
205.389.2029 Boehringer Ingelheim Investigational Site
🇭🇺Törökbálint, Hungary
205.389.2020 Boehringer Ingelheim Investigational Site
🇭🇺Veszprém, Hungary
205.389.2101 Boehringer Ingelheim Investigational Site
🇮🇱Afula, Israel
205.389.2008 Boehringer Ingelheim Investigational Site
🇭🇺Érd, Hungary
205.389.2106 Boehringer Ingelheim Investigational Site
🇮🇱Be'er-Sheva, Israel
205.389.2112 Boehringer Ingelheim Investigational Site
🇮🇱Hadera, Israel
205.389.2110 Boehringer Ingelheim Investigational Site
🇮🇱Ashkelon, Israel
205.389.2108 Boehringer Ingelheim Investigational Site
🇮🇱Holon, Israel
205.389.2107 Boehringer Ingelheim Investigational Site
🇮🇱Haifa, Israel
205.389.2111 Boehringer Ingelheim Investigational Site
🇮🇱Haifa, Israel
205.389.2104 Boehringer Ingelheim Investigational Site
🇮🇱Jerusalem, Israel
205.389.2114 Boehringer Ingelheim Investigational Site
🇮🇱Jerusalem, Israel
205.389.2102 Boehringer Ingelheim Investigational Site
🇮🇱Petah Tiqwa, Israel
205.389.2116 Boehringer Ingelheim Investigational Site
🇮🇱Nahariya, Israel
205.389.2105 Boehringer Ingelheim Investigational Site
🇮🇱Rehovot, Israel
205.389.2103 Boehringer Ingelheim Investigational Site
🇮🇱Tel Hashomer, Israel
205.389.2117 Boehringer Ingelheim Investigational Site
🇮🇱Zerifin, Israel
205.389.2211 Boehringer Ingelheim Investigational Site
🇮🇹Brescia, Italy
205.389.2206 Boehringer Ingelheim Investigational Site
🇮🇹Cagliari, Italy
205.389.2209 Boehringer Ingelheim Investigational Site
🇮🇹Ferrara, Italy
205.389.2223 Boehringer Ingelheim Investigational Site
🇮🇹Catania, Italy
205.389.2214 Boehringer Ingelheim Investigational Site
🇮🇹Genova, Italy
205.389.2215 Boehringer Ingelheim Investigational Site
🇮🇹Lecco, Italy
205.389.2221 Boehringer Ingelheim Investigational Site
🇮🇹Milano, Italy
205.389.2226 Boehringer Ingelheim Investigational Site
🇮🇹Milano, Italy
205.389.2224 Boehringer Ingelheim Investigational Site
🇮🇹Modena, Italy
205.389.2229 Boehringer Ingelheim Investigational Site
🇮🇹Pavia, Italy
205.389.2203 Boehringer Ingelheim Investigational Site
🇮🇹Montescano (PV), Italy
205.389.2230 Boehringer Ingelheim Investigational Site
🇮🇹Napoli, Italy
205.389.2201 Boehringer Ingelheim Investigational Site
🇮🇹Novara, Italy
205.389.2205 Boehringer Ingelheim Investigational Site
🇮🇹Roma, Italy
205.389.2227 Boehringer Ingelheim Investigational Site
🇮🇹Pisa, Italy
205.389.2228 Boehringer Ingelheim Investigational Site
🇮🇹Roma, Italy
205.389.2210 Boehringer Ingelheim Investigational Site
🇮🇹Sassari, Italy
205.389.2315 Boehringer Ingelheim Investigational Site
🇱🇻Balvi, Latvia
205.389.2305 Boehringer Ingelheim Investigational Site
🇱🇻Daugavpils, Latvia
205.389.2232 Boehringer Ingelheim Investigational Site
🇮🇹Treviso, Italy
205.389.2313 Boehringer Ingelheim Investigational Site
🇱🇻Jelgava, Latvia
205.389.2311 Boehringer Ingelheim Investigational Site
🇱🇻Kraslava, Latvia
205.389.2301 Boehringer Ingelheim Investigational Site
🇱🇻Riga, Latvia
205.389.2310 Boehringer Ingelheim Investigational Site
🇱🇻Riga, Latvia
205.389.2306 Boehringer Ingelheim Investigational Site
🇱🇻Talsi, Latvia
205.389.2314 Boehringer Ingelheim Investigational Site
🇱🇻Tukums, Latvia
205.389.2401 Boehringer Ingelheim Investigational Site
🇱🇹Alytus, Lithuania
205.389.2412 Boehringer Ingelheim Investigational Site
🇱🇹Vilnius, Lithuania
205.389.2405 Boehringer Ingelheim Investigational Site
🇱🇹Vilnius, Lithuania
205.389.2510 Boehringer Ingelheim Investigational Site
🇳🇱Velp, Netherlands
205.389.2604 Boehringer Ingelheim Investigational Site
🇳🇴Bekkestua, Norway
205.389.2511 Boehringer Ingelheim Investigational Site
🇳🇱Zoetermeer, Netherlands
205.389.2613 Boehringer Ingelheim Investigational Site
🇳🇴Harstad, Norway
205.389.2609 Boehringer Ingelheim Investigational Site
🇳🇴Hønefoss, Norway
205.389.2608 Boehringer Ingelheim Investigational Site
🇳🇴Lørenskog, Norway
205.389.2612 Boehringer Ingelheim Investigational Site
🇳🇴Oslo, Norway
205.389.2605 Boehringer Ingelheim Investigational Site
🇳🇴Oslo, Norway
205.389.2616 Boehringer Ingelheim Investigational Site
🇳🇴Stavanger, Norway
205.389.2708 Boehringer Ingelheim Investigational Site
🇵🇱Bialystok, Poland
205.389.2815 Boehringer Ingelheim Investigational Site
🇵🇱Dzialdowo, Poland
205.389.2764 Boehringer Ingelheim Investigational Site
🇵🇱Gdansk, Poland
205.389.2748 Boehringer Ingelheim Investigational Site
🇵🇱Kraków, Poland
205.389.2727 Boehringer Ingelheim Investigational Site
🇵🇱Leszno, Poland
205.389.2724 Boehringer Ingelheim Investigational Site
🇵🇱Lodz, Poland
205.389.2741 Boehringer Ingelheim Investigational Site
🇵🇱Lublin, Poland
205.389.2756 Boehringer Ingelheim Investigational Site
🇵🇱Olsztyn, Poland
205.389.2816 Boehringer Ingelheim Investigational Site
🇵🇱Olsztyn, Poland
205.389.2777 Boehringer Ingelheim Investigational Site
🇵🇱Szczecin - Zdunowo, Poland
205.389.2810 Boehringer Ingelheim Investigational Site
🇵🇱Tczew, Poland
205.389.2775 Boehringer Ingelheim Investigational Site
🇵🇱Torun, Poland
205.389.2710 Boehringer Ingelheim Investigational Site
🇵🇱Wodzislaw Slaski, Poland
205.389.2917 Boehringer Ingelheim Investigational Site
🇵🇹Lisboa, Portugal
205.389.3002 Boehringer Ingelheim Investigational Site
🇷🇴Bucuresti, Romania
205.389.3016 Boehringer Ingelheim Investigational Site
🇷🇴Constanta, Romania
205.389.2909 Boehringer Ingelheim Investigational Site
🇵🇹Santiago do Cacem, Portugal
205.389.3012 Boehringer Ingelheim Investigational Site
🇷🇴Bucuresti, Romania
205.389.3022 Boehringer Ingelheim Investigational Site
🇷🇴Iasi, Romania
205.389.3174 Boehringer Ingelheim Investigational Site
🇷🇺Arkhangelsk, Russian Federation
205.389.3186 Boehringer Ingelheim Investigational Site
🇷🇺Gatchina (Leningradskaya oblast), Russian Federation
205.389.3148 Boehringer Ingelheim Investigational Site
🇷🇺Ekaterinburg, Russian Federation
205.389.3104 Boehringer Ingelheim Investigational Site
🇷🇺Kazan, Russian Federation
205.389.3132 Boehringer Ingelheim Investigational Site
🇷🇺Krasnoyarsk, Russian Federation
205.389.3109 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3130 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3134 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3140 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3139 Boehringer Ingelheim Investigational Site
🇷🇺Moscow, Russian Federation
205.389.3169 Boehringer Ingelheim Investigational Site
🇷🇺Nizhny Novgorod, Russian Federation
205.389.3953 Boehringer Ingelheim Investigational Site
🇷🇺Nizhniy Novgorod, Russian Federation
205.389.3188 Boehringer Ingelheim Investigational Site
🇷🇺Murmansk, Russian Federation
205.389.3179 Boehringer Ingelheim Investigational Site
🇷🇺Pskov, Russian Federation
205.389.3110 Boehringer Ingelheim Investigational Site
🇷🇺Saratov, Russian Federation
205.389.3951 Boehringer Ingelheim Investigational Site
🇷🇺Saratov, Russian Federation
205.389.3123 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3160 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3161 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3176 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3178 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3950 Boehringer Ingelheim Investigational Site
🇷🇺St. Petersburg, Russian Federation
205.389.3101 Boehringer Ingelheim Investigational Site
🇷🇺Tomsk, Russian Federation
205.389.3133 Boehringer Ingelheim Investigational Site
🇷🇺Tomsk, Russian Federation
205.389.3102 Boehringer Ingelheim Investigational Site
🇷🇺Tomsk, Russian Federation
205.389.3144 Boehringer Ingelheim Investigational Site
🇷🇺Tomsk, Russian Federation
205.389.3194 Boehringer Ingelheim Investigational Site
🇷🇺Velikiy Novgorod, Russian Federation
205.389.3155 Boehringer Ingelheim Investigational Site
🇷🇺Yaroslavl, Russian Federation
205.389.3208 Boehringer Ingelheim Investigational Site
🇸🇰Bratislava, Slovakia
205.389.3202 Boehringer Ingelheim Investigational Site
🇸🇰Trnava, Slovakia
205.389.3207 Boehringer Ingelheim Investigational Site
🇸🇰Vrable, Slovakia
205.389.3301 Boehringer Ingelheim Investigational Site
🇸🇮Golnik, Slovenia
205.389.3304 Boehringer Ingelheim Investigational Site
🇸🇮Jesenice, Slovenia
205.389.3401 Boehringer Ingelheim Investigational Site
🇪🇸Barcelona, Spain
205.389.3403 Boehringer Ingelheim Investigational Site
🇪🇸Badalona (Barcelona), Spain
205.389.3410 Boehringer Ingelheim Investigational Site
🇪🇸Badajoz, Spain
205.389.3402 Boehringer Ingelheim Investigational Site
🇪🇸Barcelona, Spain
205.389.3428 Boehringer Ingelheim Investigational Site
🇪🇸Barcelona, Spain
205.389.3416 Boehringer Ingelheim Investigational Site
🇪🇸Cáceres, Spain
205.389.3430 Boehringer Ingelheim Investigational Site
🇪🇸Cartagena, Spain
205.389.3405 Boehringer Ingelheim Investigational Site
🇪🇸Lleida, Spain
205.389.3425 Boehringer Ingelheim Investigational Site
🇪🇸Elche, Spain
205.389.3408 Boehringer Ingelheim Investigational Site
🇪🇸Las Palmas de Gran Canarias, Spain
205.389.3404 Boehringer Ingelheim Investigational Site
🇪🇸Madrid, Spain
205.389.3414 Boehringer Ingelheim Investigational Site
🇪🇸Málaga, Spain
205.389.3552 Boehringer Ingelheim Investigational Site
🇺🇦Kiev, Ukraine
205.389.3419 Boehringer Ingelheim Investigational Site
🇪🇸Requena, Spain
205.389.3406 Boehringer Ingelheim Investigational Site
🇪🇸Madrid, Spain
205.389.3431 Boehringer Ingelheim Investigational Site
🇪🇸Pontevedra, Spain
205.389.3422 Boehringer Ingelheim Investigational Site
🇪🇸Sagunto, Spain
205.389.3427 Boehringer Ingelheim Investigational Site
🇪🇸Reus, Spain
205.389.3415 Boehringer Ingelheim Investigational Site
🇪🇸Santander, Spain
205.389.3420 Boehringer Ingelheim Investigational Site
🇪🇸San Juan, Spain
205.389.3407 Boehringer Ingelheim Investigational Site
🇪🇸Terrasa (Barcelona), Spain
205.389.3421 Boehringer Ingelheim Investigational Site
🇪🇸Santiago de Compostela, Spain
205.389.3413 Boehringer Ingelheim Investigational Site
🇪🇸Valencia, Spain
205.389.3426 Boehringer Ingelheim Investigational Site
🇪🇸Valencia, Spain
205.389.3417 Boehringer Ingelheim Investigational Site
🇪🇸Valladolid, Spain
205.389.3821 Boehringer Ingelheim Investigational Site
🇹🇷Adana, Turkey
205.389.3808 Boehringer Ingelheim Investigational Site
🇹🇷Ankara, Turkey
205.389.3810 Boehringer Ingelheim Investigational Site
🇹🇷Ankara, Turkey
205.389.3819 Boehringer Ingelheim Investigational Site
🇹🇷Erzurum, Turkey
205.389.3817 Boehringer Ingelheim Investigational Site
🇹🇷Bursa, Turkey
205.389.3827 Boehringer Ingelheim Investigational Site
🇹🇷Izmir, Turkey
205.389.3813 Boehringer Ingelheim Investigational Site
🇹🇷Izmit, Turkey
205.389.3525 Boehringer Ingelheim Investigational Site
🇺🇦Kyiv, Ukraine
205.389.3820 Boehringer Ingelheim Investigational Site
🇹🇷Kahramanmaras, Turkey
205.389.3825 Boehringer Ingelheim Investigational Site
🇹🇷Malatya, Turkey
205.389.3809 Boehringer Ingelheim Investigational Site
🇹🇷Sihhiye Ankara, Turkey
205.389.3807 Boehringer Ingelheim Investigational Site
🇹🇷Yenisehir-IZMIR, Turkey
205.389.3516 Boehringer Ingelheim Investigational Site
🇺🇦Cherkassy, Ukraine
205.389.3549 Boehringer Ingelheim Investigational Site
🇺🇦Chernivtsi, Ukraine
205.389.3511 Boehringer Ingelheim Investigational Site
🇺🇦Dnipropetrovsk, Ukraine
205.389.3510 Boehringer Ingelheim Investigational Site
🇺🇦Dnipropetrovsk, Ukraine
205.389.3506 Boehringer Ingelheim Investigational Site
🇺🇦Kharkiv, Ukraine
205.389.3523 Boehringer Ingelheim Investigational Site
🇺🇦Dnipropetrovsk, Ukraine
205.389.3533 Boehringer Ingelheim Investigational Site
🇺🇦Ivano-Frankivsk, Ukraine
205.389.3540 Boehringer Ingelheim Investigational Site
🇺🇦Lviv, Ukraine
205.389.3520 Boehringer Ingelheim Investigational Site
🇺🇦Kharkiv, Ukraine
205.389.3555 Boehringer Ingelheim Investigational Site
🇺🇦Kharkiv, Ukraine
205.389.3553 Boehringer Ingelheim Investigational Site
🇺🇦Kiev, Ukraine
205.389.3504 Boehringer Ingelheim Investigational Site
🇺🇦Kyiv, Ukraine
205.389.3526 Boehringer Ingelheim Investigational Site
🇺🇦Kyiv, Ukraine
205.389.3535 Boehringer Ingelheim Investigational Site
🇺🇦Kyiv, Ukraine
205.389.3534 Boehringer Ingelheim Investigational Site
🇺🇦Kyiv, Ukraine
205.389.3545 Boehringer Ingelheim Investigational Site
🇺🇦Lugansk, Ukraine
205.389.3530 Boehringer Ingelheim Investigational Site
🇺🇦Lviv, Ukraine
205.389.3512 Boehringer Ingelheim Investigational Site
🇺🇦Lviv, Ukraine
205.389.3554 Boehringer Ingelheim Investigational Site
🇺🇦Lviv, Ukraine
205.389.3556 Boehringer Ingelheim Investigational Site
🇺🇦m.Donetsk, Ukraine
205.389.3518 Boehringer Ingelheim Investigational Site
🇺🇦Ternopil, Ukraine
205.389.3529 Boehringer Ingelheim Investigational Site
🇺🇦Vinnitsa, Ukraine
205.389.3630 Boehringer Ingelheim Investigational Site
🇬🇧Bexhill on Sea, United Kingdom
205.389.3601 Boehringer Ingelheim Investigational Site
🇬🇧Bath, United Kingdom
205.389.3548 Boehringer Ingelheim Investigational Site
🇺🇦Zaporizhzhya, Ukraine
205.389.3605 Boehringer Ingelheim Investigational Site
🇬🇧Blackburn, United Kingdom
205.389.3640 Boehringer Ingelheim Investigational Site
🇬🇧Burbage, United Kingdom
205.389.3643 Boehringer Ingelheim Investigational Site
🇬🇧Chesterfield, United Kingdom
205.389.3627 Boehringer Ingelheim Investigational Site
🇬🇧Corsham, United Kingdom
205.389.3602 Boehringer Ingelheim Investigational Site
🇬🇧Glasgow, United Kingdom
205.389.3632 Boehringer Ingelheim Investigational Site
🇬🇧Irvine, United Kingdom
205.389.3623 Boehringer Ingelheim Investigational Site
🇬🇧London, United Kingdom
205.389.3618 Boehringer Ingelheim Investigational Site
🇬🇧Paisley, United Kingdom
205.389.3638 Boehringer Ingelheim Investigational Site
🇬🇧Middlesex, United Kingdom
205.389.3616 Boehringer Ingelheim Investigational Site
🇬🇧Newcastle upon Tyne, United Kingdom
205.389.3604 Boehringer Ingelheim Investigational Site
🇬🇧Soham, United Kingdom
205.389.3635 Boehringer Ingelheim Investigational Site
🇬🇧Wansford, Peterborough, United Kingdom
205.389.3612 Boehringer Ingelheim Investigational Site
🇬🇧Wrexham, United Kingdom
205.389.3631 Boehringer Ingelheim Investigational Site
🇬🇧Windsor, United Kingdom
205.389.1411 Boehringer Ingelheim Investigational Site
🇫🇮Mikkeli, Finland
205.389.2760 Boehringer Ingelheim Investigational Site
🇵🇱Olawa, Poland
205.389.1027 Boehringer Ingelheim Investigational Site
🇦🇹Salzburg, Austria
205.389.1220 Boehringer Ingelheim Investigational Site
🇨🇿Beroun, Czech Republic
205.389.1006 Boehringer Ingelheim Investigational Site
🇦🇹Wien, Austria
205.389.1014 Boehringer Ingelheim Investigational Site
🇦🇹Wien, Austria
205.389.1018 Boehringer Ingelheim Investigational Site
🇦🇹Wien, Austria
205.389.1021 Boehringer Ingelheim Investigational Site
🇦🇹Wien, Austria
205.389.1211 Boehringer Ingelheim Investigational Site
🇨🇿Benesov, Czech Republic
205.389.1212 Boehringer Ingelheim Investigational Site
🇨🇿Cheb, Czech Republic
205.389.1205 Boehringer Ingelheim Investigational Site
🇨🇿Havlickuv Brod, Czech Republic
205.389.1214 Boehringer Ingelheim Investigational Site
🇨🇿Lovosice, Czech Republic
205.389.1222 Boehringer Ingelheim Investigational Site
🇨🇿Ostrava, Czech Republic
205.389.1232 Boehringer Ingelheim Investigational Site
🇨🇿Praha 3, Czech Republic
205.389.1224 Boehringer Ingelheim Investigational Site
🇨🇿Praha 6 - Brevnov, Czech Republic
205.389.1201 Boehringer Ingelheim Investigational Site
🇨🇿Zatec, Czech Republic
205.389.1416 Boehringer Ingelheim Investigational Site
🇫🇮Hyvinkää, Finland
205.389.1404 Boehringer Ingelheim Investigational Site
🇫🇮Lahti, Finland
205.389.1417 Boehringer Ingelheim Investigational Site
🇫🇮Lappeenranta, Finland
205.389.1409 Boehringer Ingelheim Investigational Site
🇫🇮Pori, Finland
205.389.2307 Boehringer Ingelheim Investigational Site
🇱🇻Riga, Latvia
205.389.2406 Boehringer Ingelheim Investigational Site
🇱🇹Kaunas, Lithuania
205.389.2409 Boehringer Ingelheim Investigational Site
🇱🇹Kaunas, Lithuania
205.389.2414 Boehringer Ingelheim Investigational Site
🇱🇹Vilnius, Lithuania
205.389.2610 Boehringer Ingelheim Investigational Site
🇳🇴Harstad, Norway
205.389.2762 Boehringer Ingelheim Investigational Site
🇵🇱Bialystok, Poland
205.389.2778 Boehringer Ingelheim Investigational Site
🇵🇱Bielsko-Biala, Poland
205.389.2706 Boehringer Ingelheim Investigational Site
🇵🇱Bienkowka 410, Poland
205.389.2723 Boehringer Ingelheim Investigational Site
🇵🇱Gdansk, Poland
205.389.2798 Boehringer Ingelheim Investigational Site
🇵🇱Krakow, Poland
205.389.2776 Boehringer Ingelheim Investigational Site
🇵🇱Lublin, Poland
205.389.2726 Boehringer Ingelheim Investigational Site
🇵🇱Pabianice, Poland
205.389.2703 Boehringer Ingelheim Investigational Site
🇵🇱Poznan, Poland
205.389.2769 Boehringer Ingelheim Investigational Site
🇵🇱Poznan, Poland
205.389.1130 Boehringer Ingelheim Investigational Site
🇧🇪Quaregnon, Belgium
205.389.1861 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.1931 Boehringer Ingelheim Investigational Site
🇩🇪Berlin, Germany
205.389.2027 Boehringer Ingelheim Investigational Site
🇭🇺Budapest, Hungary